Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to -$2.9 million.

  • Prestige Consumer Healthcare's Cash from Investing Activities fell 44.50% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year increase of 23.23%. This contributed to the annual value of -$17.5 million for FY2025, which is 13.22% up from last year.
  • According to the latest figures from Q3 2025, Prestige Consumer Healthcare's Cash from Investing Activities is -$2.9 million, which was down 51.14% from -$1.9 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's Cash from Investing Activities' 5-year high stood at $2.3 million during Q2 2023, with a 5-year trough of -$231.7 million in Q3 2021.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$2.9 million (2023), whereas its average is -$4.4 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Cash from Investing Activities plummeted by 2,455.33% in 2021, and later surged by 321.87% in 2023.
  • Prestige Consumer Healthcare's Cash from Investing Activities (Quarterly) stood at -$20.2 million in 2021, then surged by 91.09% to -$1.8 million in 2022, then crashed by 149.36% to -$4.5 million in 2023, then crashed by 118.33% to -$9.8 million in 2024, then plummeted by 44.50% to -$2.9 million in 2025.
  • Its Cash from Investing Activities stands at -$2.9 million for Q3 2025, versus -$1.9 million for Q2 2025 and -$3.5 million for Q1 2025.